General Archive
-
News releases
MRC Technology Negotiates Licence Deal with Quantifoil Micro Tools GmbH for Ultrastable Gold Support (UltrAuFoil) Technology
MRC Technology announced it has negotiated a licence for ultrastable gold supports developed at the MRCLaboratory of Molecular Biology, with…
-
News releases
MRC Technology and Cyclofluidic announce the successful completion of a hit optimisation project
MRC Technology (MRCT) and Cyclofluidic Ltd have announced the successful completion of their collaboration to identify and optimise drug-like molecules…
-
News releases
First Treatment Approved under EAMS Developed Using MRC Technology Antibody Humanization Expertise
Pembrolizumab, humanized by MRC Technology, is the the first drug to be approved through the Early Access to Medicine Scheme…
-
News releases
Respiratory ‘Call for Targets’ launched
‘Call for targets’ launched to find new therapeutic concepts for treatment of respiratory disease, including conditions such as allergy, acute…
-
News releases
MRC Technology appoints General Counsel and Company Secretary
Dr Edward Bliss appointed in new role of General Counsel and Company Secretary.
-
News releases
MRC Technology to manage Diabetes UK’s IP
MRC Technology has signed an agreement with Diabetes UK to manage its intellectual property (IP). The partnership will enable Diabetes…
-
News releases
Key US Patents Granted for GPCR-Focused Drug Discovery Platform Arising From Pioneering Research and Translational Expertise at MRC and MRC Technology
Heptares Therapeutics (Heptares) recently announced the grant of multiple key patents in the United States relating to its GPCR-focused drug…
-
News releases
MRC Technology calls for diagnostic collaboration
MRC Technology is inviting potential partners with early stage RNA, DNA and/or protein-based diagnostics to submit details and explore collaborative…
-
News releases
MRC Technology welcomes launch of Knowledge Quarter
MRC Technology is a member of the newly launched Knowledge Quarter, set up to create a vibrant knowledge hub by…
-
News releases
MRC Technology and Shandong International Biotechnology Park (China) to cooperate in new drug for Alzheimer’s
MRC Technology and Shandong International Biotechnology Park (BIOasis) have signed a partnership agreement for the development of a new Alzheimer’s…
-
News releases
MRC Technology and Yabao Pharmaceuticals Announce Exclusive Partnership in China to Develop Novel Therapeutics for Parkinson’s Disease
New partnership with Yabao Pharmaceutical Co, Inc. to discover, develop and commercialise innovative compounds targeting a specific kinase involved in…
-
News releases
Charities pledge to jump start drug development for brain diseases
The Neurodegeneration Medicines Acceleration Programme (Neuro-MAP), led by medical research charity MRC Technology, will see charities and funding bodies identify…